BIT:FF • IT0005215329
The current stock price of FF.MI is 11.25 EUR. Today FF.MI is down by -3.43%. In the past month the price increased by 7.66%. In the past year, price increased by 56.25%.
ChartMill assigns a technical rating of 10 / 10 to FF.MI. When comparing the yearly performance of all stocks, FF.MI is one of the better performing stocks in the market, outperforming 87.95% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to FF.MI. FF.MI has an average financial health and profitability rating.
12 analysts have analysed FF.MI and the average price target is 13.12 EUR. This implies a price increase of 16.6% is expected in the next year compared to the current price of 11.25.
For the next year, analysts expect an EPS growth of 53.89% and a revenue growth 4.41% for FF.MI
Over the last trailing twelve months FF.MI reported a non-GAAP Earnings per Share(EPS) of 0.89. The EPS increased by 147.03% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 5.07% | ||
| ROA | 6.89% | ||
| ROE | 13.58% | ||
| Debt/Equity | 0.44 |
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| SRT3 | SARTORIUS AG-VORZUG | 37.12 | 17.994B | ||
| DIM | SARTORIUS STEDIM BIOTECH | 31.3 | 17.49B | ||
| 56S1 | SARTORIUS STEDIM BIOTECH | 33.66 | 17.485B | ||
| SRT | SARTORIUS AG | 29.45 | 13.868B | ||
| QIA | QIAGEN N.V. | 17.67 | 8.507B | ||
| 1SXP | SCHOTT PHARMA AG& CO KGAA | 12.4 | 2.19B | ||
| EVT | EVOTEC SE | N/A | 2.019B | ||
| GXI | GERRESHEIMER AG | 5.37 | 556.785M | ||
| ALECR | EUROFINS CEREP-REGR | N/A | 159M | ||
| MLC | MALIN CORP PLC | N/A |
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Milan Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
Fine Foods & Pharmaceuticals N.T.M. The company is headquartered in Verdellino, Bergamo and currently employs 660 full-time employees. The company went IPO on 2016-10-19. The company is specialized in the manufacturing of pharmaceutical products for third parties. The firm manages three segments: Pharmaceuticals, Nutraceuticals and Medical Devices. The Pharmaceuticals segment includes powders and granules, tablets, coated tablets and hard gelatin capsules, packaged in sachets, blisters and bottles. The Nutraceuticals segment includes soluble and effervescent powders and granules, soluble, effervescent and chewable tablets, coated tablets and hard gelatin capsules packaged in bags, sachets, sticks, jars, tablet bottles, blisters and strips. The Medical Devices segment includes tablets, capsules, powders, granules and cover the areas for gastrointestinal, oral and throat treatment and the weight management. Medical Devices marked CE (European Conformity) are available for licensing.
FINE FOODS & PHARMACEUTICALS
Via Berlino, 39, Zingonia
Verdellino BERGAMO IT
Employees: 779
Phone: 390354821382
Fine Foods & Pharmaceuticals N.T.M. The company is headquartered in Verdellino, Bergamo and currently employs 660 full-time employees. The company went IPO on 2016-10-19. The company is specialized in the manufacturing of pharmaceutical products for third parties. The firm manages three segments: Pharmaceuticals, Nutraceuticals and Medical Devices. The Pharmaceuticals segment includes powders and granules, tablets, coated tablets and hard gelatin capsules, packaged in sachets, blisters and bottles. The Nutraceuticals segment includes soluble and effervescent powders and granules, soluble, effervescent and chewable tablets, coated tablets and hard gelatin capsules packaged in bags, sachets, sticks, jars, tablet bottles, blisters and strips. The Medical Devices segment includes tablets, capsules, powders, granules and cover the areas for gastrointestinal, oral and throat treatment and the weight management. Medical Devices marked CE (European Conformity) are available for licensing.
The current stock price of FF.MI is 11.25 EUR. The price decreased by -3.43% in the last trading session.
FINE FOODS & PHARMACEUTICALS (FF.MI) has a dividend yield of 1.21%. The yearly dividend amount is currently 0.12.
FF.MI has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
12 analysts have analysed FF.MI and the average price target is 13.12 EUR. This implies a price increase of 16.6% is expected in the next year compared to the current price of 11.25.
The Revenue of FINE FOODS & PHARMACEUTICALS (FF.MI) is expected to grow by 4.41% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.